INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "AZD1390, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN COMBINATION WITH RADIATION FOR USE IN A METHOD OF TREATMENT OF A CENTRAL NERVOUS SYSTEM (CNS) TUMOUR"

GENEVA, Sept. 21 -- ASTRAZENECA AB (SE-151 85 Sodertalje) filed a patent application (PCT/EP2025/056638) for "AZD1390, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN COMBINATION WITH RADIATION FOR USE IN A METHOD OF TREATMENT OF A CENTRAL NERVOUS SYSTEM (CNS) TUMOUR" on Mar 11, 2025. With publication no. WO/2025/190957, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GLOVER, Colin Paul Jonathan (ASTRAZENECA UK LIMITED, 1 Francis Crick Avenue,Cambridge Biomedical CampusCambridgeCambridgeshire CB2 0AA), POLANSKA, Urszula...